Professor Steve Schey is a Professor of Haematology based at King's College Hospital in London.
Prof Schey qualified at St George's Hospital in 1974, and later travelled to Australia where he worked at the Institute of Clinical Pathology and Medical Research in Sydney as Clinical Lecturer in Haematology.
He returned to London where he was the Bone Marrow Transplant Co-ordinator at the Royal Free Hospital and then the Royal Marsden. Later he moved to the Middlesex Hospital and subsequently served as Director of Clinical Haematology for the Guy's/St Thomas' Trust from 1993-2004 before moving to King’s College Hospital in 2005.
Professor Steve Schey was Secretary and then Chair of the UK Myeloma Forum 1999-2009. He has been Clinical Lead for South East Thames Cancer Network, since 2005. In addition, he is amember of the National Cancer Research Institute (NCRI) Haemoncology Cancer Steering Group, the NCRI Industry Adoption Panel and Chairman of the NCRI Myeloma Clinical Trials Committee.
Professor Stephen Mackinnon is a Professor of Haematology based at University College London.
Prof Mackinnon leads the bone marrow and stem cell program at UCL. He attended medical school at the University of Glasgow. He subsequently trained in Internal Medicine and Haemato-oncology in Glasgow. This was followed by a transplant fellowship at the Hammersmith Hospital in London where he developed an interest in graft-versus-leukaemia reactions. In 1990 he moved to Memorial Sloan Kettering Cancer Center in New York to continue this work in both the clinic and the lab. He made the use of donor lymphocytes less toxic by limiting the T cell dose administered to transplant recipients allowing separation of graft-versus-leukaemia responses from graft-versus-host disease.
In 1995 he returned to University College London to his current position. He became the Clinical and Academic Head of Department at the Royal Free Campus in 2004 and has recruited a highly effective and productive group of clinical and laboratory haematologists. He is an expert in the treatment of leukaemia, lymphoma, myeloma and in the use of bone marrow and stem cell transplantation to promote long-term cure of haematological malignancies. Current research interests include adoptive immunotherapy and immune reconstitution following allogeneic stem cell transplantation.
Stephen is a keen golfer whose desire to have a single figure handicap has been thwarted partly by his career choices, but primarily by a lack of real talent.
Professor Stephen Devereux is a Consultant Haematologist based at King's College Hospital in London. He is also Professor in Lymphoma Biology at King's College London.
Professor Devereus trained in Haematology at the Royal Free and University College London Hospitals where he also worked as a Senior Lecturer.
Professor Devereux has extensive experience in the diagnosis and treatment of blood cancers with a particular interest in lymphoid malignances and chronic lymphatic leukaemia. He plays an active role in both laboratory and clinical research and directs an internationally competitive team working on the biology of lymphoma at King's College London.
Professor Devereux is Clinical Director of the London South Comprehensive Local Research Network and the South East London Cancer Research Network. He is a medical advisor to the Lymphoma Association and serves on the executive of the UK-CLL forum executive, the NCRN CLL subgroup and the Leukaemia and Lymphoma Research Fund Clinical Trials Committee.
Dr Samir Agrawal is a Consultant Haematologist based at St Bartholomew's Hospital in London.
Dr Agrawal qualified initially at the University of Bristol subsequently training at The Royal Marsden Cancer Hospitals and being awarded his PhD (in Immunology) at the University of Paris. A former national junior chess champion, Dr Agrawal today is also Director of The Stem Cell Laboratory (at St Bartholomew's) and Head of Diagnostic Immunophenotyping in addition to his consultant and teaching roles.
Dr Agrawal sits on several bodies reviewing outcomes in haemato-oncology, and was a winner of one of the NHS Innovator Awards in 2006 for his work on the introduction of new diagnostic tests for the diagnosis of human leukaemias. A fluent French speaker, he also runs a specialist translation service preparing clinical and scientific medical articles originally written in French for publication in international English/American medical literature.
Dr Majid Kazmi is a Consultant Haematologist based at Guy’s & St Thomas’ NHS Foundation Trust and King’s College Hospital NHS Foundation Trust.
Dr Kazmi qualified from the University of Aberdeen in 1991 with Commendation. He has been a consultant in Haemato-oncology since 2001.
Currently Dr Kazmi is the Lead Cancer Clinician and Clinical Director of Oncology & Haematology at Guy’s & St Thomas’. He is also medical director for commercial activities at the Trust. He is Chair of the Haemato-oncology pathway group on behalf of the London Cancer Alliance covering the population of South London and NW London (5 million people).
His clinical interests include Myeloma where he has been the UK Chief Investigator for a number of national and international studies. He sits on the UK guidelines group for Myeloma and Amyloidosis. He has extensive experience in Transplantation and is the UK lead for transplantation in auto-immune diseases for EBMT (European Group for Blood and Marrow Transplantation).
Dr Kazmi is a member of European group for Blood and Marrow Transplantation (EBMT) and American Society of Haematology (ASH), American Society of Haematology, British Society of Marrow Transplantation and the European Group for Blood and Marrow transplantation.
Dr Maged Gharib is a Consultant Haematologist based at St Helen's and Knowsley Teaching Hospitals NHS Trust.
Dr Gharib graduated from Cairo University in 1990. He undertook 6 years of general medical training in Cairo then Coventry, before specialist Haematology training at University Hospitals of Edinburgh, Cardiff and Manchester.
Dr Gharib took his first Consultant Haematologist post at Alder Hey Hospital as a Paediatric Haematologist. He then moved to Manchester in 2006 to take up a consultant post in paediatric stem cell transplantation.
In 2010 he moved on to St Helens' Teaching Hospitals. In addition to his expertise in the management of a wide range of haematological malignancies (Lymphoma, Leukaemia and Myeloma), he is an expert in the management of cancer associated thrombosis (blood clots).
Dr Gharib is a member of the Royal College of Physicians; Royal College of Pathologists; British Society for Haematology and the European Haematology Association.
Professor Jamie Cavenagh is a Professor of Haematology based at Barts Health NHS Trust.
Prof Cavenagh qualified with MB BS in 1985 from St Marys Hospital Medical School, London. He trained in clinical haematology at St Georges Hospital, The Royal Marsden Hospital and Barts and The London.
Professor Cavenagh was a Leukaemia Research Fund Scientific Training Fellow from 1992-1994 and he is currently the Chairman of the UK Myeloma Forum.
Dr Beatrice Seddon is a Consultant Clinical Oncologist based at University College Hospital, London.
Dr Seddon is based on the Sarcoma Unit at UCH, which together with the Bone Tumour Unit at the Royal National Orthopaedic Hospital, comprises the London Bone and Soft Tissue Tumour Service.
She trained in treating sarcomas at the Royal Marsden and Middlesex Hospitals in London, and now specialises exclusively in the treatment of soft tissue and bone sarcomas with chemotherapy and radiotherapy.
Dr Sunil Gupta is a Consultant Haematologist based at East Sussex Healthcare NHS Trust (Conquest Hospital).
Dr Gupta has over 20 years of experience in Clinical and Laboratory Haematology. He began his training in India at the Institute of Medical Sciences New Delhi, and continued training in Singapore’s National University Hospital and the Royal North Shore Hospital, Sydney Australia, before joining Kings College Hospital, London in 2004. He completed full formal training under London Deanery at Kings and attained completion certificate in specialist training. He has done research in paediatric haematology and his thesis was on anthracycline toxicity in children. He wanted to broaden his horizon in haeamtology and thus completed MRCP (internal medicine) and FRCPath (haematology) and now has solely an adult haematology-oncology practice.
Dr Gupta has been working as a Consultant Haematologist since May 2011. He joined Conquest and Eastbourne Hospitals as Consultant Haematologist in September 2012. His area of speciality is Haematology-oncology but has keen interest in clotting disorders as well. Dr Gupta offers diagnostic and treatment services of various primary blood disorders and chemotherapy related to Lymphoma and Multiple Myeloma is available for private patients.
Dr Gupta is a member of the British Society of Haematology, European Haematology Association, Medical Protection Society and the American Society of Haematology.
Dr Shankara Paneesha is a Consultant Haematologist based at The Heart of England NHS Foundation Trust in Birmingham.
Dr Paneesha also consults at Spire Little Aston & Spire Parkway Hospitals.
He graduated from Mysore University in 1993 and obtained postgraduate qualification in General Medicine from Bombay University in 1996.
He completed specialist training in hematology from the West Midlands Deanery following initial training at the Royal Free and the Royal Marsden Hospitals in London. He undertook a period of research in myeloma and venous thrombosis at Warwick University. He has an excellent experience in the treatment of hematological malignancies including leukemia, lymphoma, and myeloma, investigation of thrombosis risk factors and inherited thrombophilia and stem cell transplantation.
He was appointed as a Consultant hematologist in March 2007 at the Heart of England NHS Foundation Trust. His main interests are malignant hematology, Stem Cell Transplantation and venous thrombosis. He has published research in top international hematology journals.
He takes part in a large number of trials in Haemato-oncology either as a principal investigator or as co-investigator at his institution.